Evidence over hype.
Practice over protocol.
Protocol-driven and longevity medicine sits at an interesting edge — fast moving literature, off-label prescribing, and a public conversation often louder than the data. Vitale Health is committed to honest, evidence-anchored practice.
Evidence first
Every molecule we offer has peer-reviewed clinical literature behind it. Provider notes include the evidence base and known risk profile.
On-label and off-label
Some therapies are prescribed on-label; others are prescribed off-label by a licensed provider — a common and legally permitted practice in the United States when supported by clinical judgment.
Personalization beats protocols
A molecule that helps one member may be wrong for another. Dose, route, frequency, and stack are personalized to the individual.
Continuous re-evaluation
Protocols are revisited at quarterly check-ins or sooner if symptoms or goals shift. Dose adjustments and discontinuation are part of normal care.
Conservative with risk
We say no when the risk-benefit balance is unfavorable. There are members we decline and protocols we will not run.
No guaranteed outcomes
Biology varies. We are transparent about what is known, what is uncertain, and where the literature is thin.
A starting point.
The literature behind each molecule is summarized in your provider's protocol notes. Below is a small starting selection — your provider can share more on request.
- REFFrias JP, Davies MJ, Rosenstock J, et al. Tirzepatide vs Semaglutide in Type 2 Diabetes. N Engl J Med. 2021.
- REFJastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for Chronic Weight Management. N Engl J Med. 2022.
- REFSikiric P, et al. Stable Gastric Pentadecapeptide BPC 157 — therapeutic outlook. Curr Pharm Des. 2018.
- REFMannick JB, et al. mTOR inhibition and immune function in older adults. Sci Transl Med. 2018.
- REFKhavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity. Bull Exp Biol Med. 2003.
Talk to a provider.
Submit an intake and a licensed physician will follow up — usually within one business day.